# A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

> **NCT04104685** · PHASE2 · COMPLETED · sponsor: **Vyne Therapeutics Inc.** · enrollment: 446 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **COMBINATION_PRODUCT:** FCD105
- **DRUG:** 3% Minocycline Foam
- **DRUG:** 0.3% Adapalene Foam
- **OTHER:** Vehicle Foam

## Key facts

- **NCT ID:** NCT04104685
- **Lead sponsor:** Vyne Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-18
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-03-03
- **Target enrollment:** 446 (ACTUAL)
- **Last updated:** 2021-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04104685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04104685, "A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04104685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*